BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brioschi A, Zara GP, Calderoni S, Gasco MR, Mauro A. Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules 2008;13:230-54. [PMID: 18305415 DOI: 10.3390/molecules13020230] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Brioschi AM, Calderoni S, Zara GP, Priano L, Gasco MR, Mauro A. Solid lipid nanoparticles for brain tumors therapy. Nanoneuroscience and Nanoneuropharmacology. Elsevier; 2009. pp. 193-223. [DOI: 10.1016/s0079-6123(08)80011-8] [Cited by in Crossref: 9] [Article Influence: 0.7] [Reference Citation Analysis]
2 Sena CFA, Apolinário LS, Duarte JA, dos Santos GC, Monteiro LOF, de Oliveira MC, Leite EA, de Oliveira RB. Preformulation and formulation development of a bioactive nitroaromatic compound. J Nanopart Res 2017;19. [DOI: 10.1007/s11051-017-4073-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Souto EB, Müller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 2010;:115-41. [PMID: 20217528 DOI: 10.1007/978-3-642-00477-3_4] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 9.5] [Reference Citation Analysis]
4 Soares AMS, Hungerford G, Costa SPG, Gonçalves MST. Aminobenzocoumarinylmethyl esters as photoactive precursors for the release of butyric acid. New J Chem 2015;39:7227-33. [DOI: 10.1039/c5nj00699f] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Smolkova B, Dusinska M, Gabelova A. Nanomedicine and epigenome. Possible health risks. Food Chem Toxicol 2017;109:780-96. [PMID: 28705729 DOI: 10.1016/j.fct.2017.07.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
6 Lasa-saracibar B, Estella-hermoso de Mendoza A, Guada M, Dios-vieitez C, Blanco-prieto MJ. Lipid nanoparticles for cancer therapy: state of the art and future prospects. Expert Opinion on Drug Delivery 2012;9:1245-61. [DOI: 10.1517/17425247.2012.717928] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
7 Su M, He Y, Xue S, Yu J, Ren X, Huang N, Abdullahi R, Xu M. Butyric acid alleviated chronic intermittent hypoxia-induced lipid formation and inflammation through up-regulating HuR expression and inactivating AMPK pathways. Biosci Rep 2021;41:BSR20203639. [PMID: 33876818 DOI: 10.1042/BSR20203639] [Reference Citation Analysis]
8 Galvin P, Thompson D, Ryan KB, Mccarthy A, Moore AC, Burke CS, Dyson M, Maccraith BD, Gun’ko YK, Byrne MT, Volkov Y, Keely C, Keehan E, Howe M, Duffy C, Macloughlin R. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications. Cell Mol Life Sci 2012;69:389-404. [DOI: 10.1007/s00018-011-0856-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
9 Soares AMS, Piloto AM, Hungerford G, Costa SPG, Gonçalves MST. Photolytic Release of Butyric Acid from Oxygen- and Nitrogen-Based Heteroaromatic Cages. Eur J Org Chem 2012;2012:922-30. [DOI: 10.1002/ejoc.201101392] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
10 Güney G, Kutlu HM, Genç L. Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects. Colloids Surf B Biointerfaces 2014;121:270-80. [PMID: 24985762 DOI: 10.1016/j.colsurfb.2014.05.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
11 Rawal SU, Patel MM. Lipid nanoparticulate systems. Lipid Nanocarriers for Drug Targeting. Elsevier; 2018. pp. 49-138. [DOI: 10.1016/b978-0-12-813687-4.00002-5] [Cited by in Crossref: 12] [Article Influence: 3.0] [Reference Citation Analysis]
12 Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210 [PMID: 28694660 DOI: 10.3748/wjg.v23.i23.4200] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
13 Li R, Lim S, Choi H, Lee M. Solid Lipid Nanoparticles as Drug Delivery System for Water-Insoluble Drugs. Journal of Pharmaceutical Investigation 2010;40:63-73. [DOI: 10.4333/kps.2010.40.s.063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cao S, Slack SD, Levy CN, Hughes SM, Jiang Y, Yogodzinski C, Roychoudhury P, Jerome KR, Schiffer JT, Hladik F, Woodrow KA. Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal. Sci Adv 2019;5:eaav6322. [PMID: 30944862 DOI: 10.1126/sciadv.aav6322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
15 Rezzani R, Rodella LF, Fraschini F, Gasco MR, Demartini G, Musicanti C, Reiter RJ. Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage. Journal of Pineal Research 2009;46:255-61. [DOI: 10.1111/j.1600-079x.2008.00651.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
16 Liu J, Wang F, Luo H, Liu A, Li K, Li C, Jiang Y. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. International Immunopharmacology 2016;30:179-87. [DOI: 10.1016/j.intimp.2015.11.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
17 Battaglia L, Gallarate M. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 2012;9:497-508. [PMID: 22439808 DOI: 10.1517/17425247.2012.673278] [Cited by in Crossref: 171] [Cited by in F6Publishing: 150] [Article Influence: 17.1] [Reference Citation Analysis]
18 Shashni B, Tajika Y, Nagasaki Y. Design of enzyme-responsive short-chain fatty acid-based self-assembling drug for alleviation of type 2 diabetes mellitus. Biomaterials 2021;275:120877. [PMID: 34062420 DOI: 10.1016/j.biomaterials.2021.120877] [Reference Citation Analysis]
19 Minelli R, Occhipinti S, Gigliotti CL, Barrera G, Gasco P, Conti L, Chiocchetti A, Zara GP, Fantozzi R, Giovarelli M, Dianzani U, Dianzani C. Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. Br J Pharmacol 2013;170:233-44. [PMID: 23713413 DOI: 10.1111/bph.12255] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
20 Ying K, Bai B, Gao X, Xu Y, Wang H, Xie B. Orally Administrable Therapeutic Nanoparticles for the Treatment of Colorectal Cancer. Front Bioeng Biotechnol 2021;9:670124. [PMID: 34307319 DOI: 10.3389/fbioe.2021.670124] [Reference Citation Analysis]
21 Magadán S, Mikelez-Alonso I, Borrego F, González-Fernández Á. Nanoparticles and trained immunity: Glimpse into the future. Adv Drug Deliv Rev 2021;175:113821. [PMID: 34087325 DOI: 10.1016/j.addr.2021.05.031] [Reference Citation Analysis]
22 Campos-vega R, Guevara-gonzalez R, Guevara-olvera B, Dave Oomah B, Loarca-piña G. Bean (Phaseolus vulgaris L.) polysaccharides modulate gene expression in human colon cancer cells (HT-29). Food Research International 2010;43:1057-64. [DOI: 10.1016/j.foodres.2010.01.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
23 Mura S, Bui DT, Couvreur P, Nicolas J. Lipid prodrug nanocarriers in cancer therapy. J Control Release 2015;208:25-41. [PMID: 25617724 DOI: 10.1016/j.jconrel.2015.01.021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 9.3] [Reference Citation Analysis]
24 Genç L, Kutlu HM, Güney G. Vitamin B 12 -loaded solid lipid nanoparticles as a drug carrier in cancer therapy. Pharmaceutical Development and Technology 2013;20:337-44. [DOI: 10.3109/10837450.2013.867447] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
25 Maarman GJ. Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension. Adv Exp Med Biol 2017;967:161-78. [PMID: 29047086 DOI: 10.1007/978-3-319-63245-2_10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
26 Jătariu AN, Popa M, Peptu CA. Different particulate systems--bypass the biological barriers? J Drug Target 2010;18:243-53. [PMID: 19883240 DOI: 10.3109/10611860903398099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Souto EB, Doktorovová S. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. Methods Enzymol 2009;464:105-29. [PMID: 19903552 DOI: 10.1016/S0076-6879(09)64006-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
28 Smolkova B, El Yamani N, Collins AR, Gutleb AC, Dusinska M. Nanoparticles in food. Epigenetic changes induced by nanomaterials and possible impact on health. Food Chem Toxicol 2015;77:64-73. [PMID: 25554528 DOI: 10.1016/j.fct.2014.12.015] [Cited by in Crossref: 82] [Cited by in F6Publishing: 59] [Article Influence: 10.3] [Reference Citation Analysis]
29 Gedda MR, Babele PK, Zahra K, Madhukar P. Epigenetic Aspects of Engineered Nanomaterials: Is the Collateral Damage Inevitable? Front Bioeng Biotechnol 2019;7:228. [PMID: 31616663 DOI: 10.3389/fbioe.2019.00228] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
30 Minelli R, Serpe L, Pettazzoni P, Minero V, Barrera G, Gigliotti C, Mesturini R, Rosa AC, Gasco P, Vivenza N. Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. Br J Pharmacol. 2012;166:587-601. [PMID: 22049973 DOI: 10.1111/j.1476-5381.2011.01768.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
31 Cao S, Jiang Y, Levy CN, Hughes SM, Zhang H, Hladik F, Woodrow KA. Optimization and comparison of CD4-targeting lipid-polymer hybrid nanoparticles using different binding ligands. J Biomed Mater Res A 2018;106:1177-88. [PMID: 29271128 DOI: 10.1002/jbm.a.36315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]